Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Reaction - Real Life Use of Ravulizumab in Italian Patients with Paroxysmal Nocturnal Hemoglobinuria a Multicenter Observational Retrospective and Prospective Cohort Study, Final Results

Blood (2024) 144 (Supplement 1): 2464.

https://doi.org/10.1182/blood-2024-204659

Published: 2024

Journal Articles

Patient Specific Droplet Digital PCR Targeting FLT3-ITD Allows to Detect Small Clones in Acute Leukemias at Diagnosis and during Follow-up

Daniela Cilloni, Johanna Umurungi, Valentina Bonuomo, Federico Itri, Cristina Rotolo, Silvia Marini, Monia Lunghi, Andrea Castelli, Carmen Fava, Giuseppe Saglio, Alessandro Cignetti, Jessica Petiti

Blood (2022) 140 (Supplement 1): 11827–11828.

https://doi.org/10.1182/blood-2022-167017

Published: 2022

Journal Articles

A Chemo-Free Bridge-to-Transplant Strategy with Venetoclax and Azacitidine for NPM1 -Mutated Acute Myeloid Leukemia in Molecular Failure

Chiara Sartor, Lorenzo Brunetti, Ernesta Audisio, Alessandro Cignetti, Letizia Zannoni, Gianluca Cristiano, Jacopo Nanni, Emanuela Ottaviani, Lorenza Bandini, Sarah Parisi, Stefania Paolini, Sofia Sciabolacci, Valeria Cardinali, Cristina Papayannidis, Michele Cavo, Maria Paola Martelli, Antonio Curti

Blood (2022) 140 (Supplement 1): 9034–9035.

https://doi.org/10.1182/blood-2022-165914

Published: 2022

Journal Articles

CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program

Blood (2021) 138 (Supplement 1): 1262.

https://doi.org/10.1182/blood-2021-153028

Published: 2021

Journal Articles

Italian Observational Study on Real-Life Use of Venetoclax in Acute Myeloid Leukemia (AVALON study): Results of Interim Analysis on Relapsed/Refractory Patients

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-143082

Published: 2020

Journal Articles

Interleukin-2 Receptor Alpha Chain, Also Called CD25, Is a Potential Target in Acute Lymphoblastic Leukemia

Giovanna Carrà, PhD, Antonio Cartellà, MD, Beatrice Maffeo, Paola Circosta, PhD, Alessandro Cignetti, MD PhD, Marisa Pautasso, MD, Ubaldo Familiari, MD, Marco Volante, MD, Matteo Emidio Emidio Dragani, MD, Giovanna Rege Cambrin, MDPhD, Giuseppe Saglio, MD PhD, Alessandro Morotti, MDPhD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-139970

Published: 2020

Journal Articles

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Immunolipsome Loaded Venetoclax

Mohammad Houshmand, PhD, Paola Circosta, PhD, Francesca Garello, PhD, Valentina Gaidano, MD, Alessandro Cignetti, MD PhD, Rachele Stefania, Silvio Aime, PhD, Giuseppe Saglio, MD PhD

Blood (2020) 136 (Supplement 1): 39.

https://doi.org/10.1182/blood-2020-142540

Published: 2020

Journal Articles

A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-center Study of FLT3 mutated AML patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitors Administration in the Real-Life Clinical Practice

Blood (2020) 136 (Supplement 1): 32–34.

https://doi.org/10.1182/blood-2020-139981

Published: 2020

Journal Articles

B-ALL/NHL 2002 GMALL Protocol As First-Line Treatment in Patients with Double-Hit Lymphoma: Favorable Results in18 Consecutive Patients from Two Italian Institutions

Safaa M. Ramadan, PhD MD, Alessandro Cignetti, MD PhD, Simona Sammassimo, MD, Enrico Derenzini, MD PhD, Giusy Ceparano, MD, Tommaso Radice, MD, Federica Gigli, MD, Stefano Fiori, MD, Valentina Tabanelli, MD, Martina Milani, Emanuela Omodeo Sale', Sara Gandini, PhD, Daniela Gottardi, MD, Giuseppe Saglio, MD, Stefano Pileri, MD, Corrado Tarella, MD

Blood (2019) 134 (Supplement_1): 1631.

https://doi.org/10.1182/blood-2019-128794

Published: 2019

Journal Articles

Prognostic Impact of the Baseline Immunologic Profile in Patients with Aggressive B Non-Hodgkin Lymphomas

Safaa M. Ramadan, PhD MD, Giusy Ceparano, MD, Alessandro Cignetti, MD PhD, Simona Sammassimo, MD, Vincenzo Bagnardi, Eleonora Pagan, Daniela Gottardi, MD, Stefano Fiori, MD, Rita Passerini, Tommaso Radice, MD, Giuseppe Saglio, MD, Corrado Tarella, MD

Blood (2019) 134 (Supplement_1): 1522.

https://doi.org/10.1182/blood-2019-132237

Published: 2019

Journal Articles

Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia

Valentina Gaidano, MD, Paola Circosta, PhD, Alessandro Cignetti, MD PhD, Mohammad Houshmand, Nicoletta Vitale, PhD, Stefano Sainas, PhD, Agnese Pippione, PhD, Manuela Marraudino, PhD, Brigitta Bonaldo, MD, Marta Giorgis, PhD, Donatella Boschi, PhD, Marco Lucio Lolli, PhD, Giuseppe Saglio, MD

Blood (2019) 134 (Supplement_1): 3942.

https://doi.org/10.1182/blood-2019-128085

Published: 2019

Journal Articles

Low Circulating B Lymphocytes in Newly Diagnosed Follicular and Diffuse Large B Cell Lymphoma: Differences Compared to Normal Subjects and Possible Prognostic Role

Riccardo Bruna, Massimo Geuna, Delia Rota Scalabrini, MD, Alessandro Cignetti, MD PhD, Nathalie Santoro, Daniela Gottardi, MD, Roberto Passera, Corrado Tarella, MD Prof

Blood (2017) 130 (Supplement 1): 1482.

https://doi.org/10.1182/blood.V130.Suppl_1.1482.1482

Published: 2017

Journal Articles

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

Blood (2015) 125 (4): 600–605.

https://doi.org/10.1182/blood-2014-05-576157

Published: 2015

Includes: Supplemental data

Journal Articles

Normal Circulating B Cells Are Markedly Reduced in Follicular Lymphoma and Diffuse Large B Cell Lymphoma at Diagnosis

Massimo Geuna, PhD, Bruna Riccardo, MD, Alessandro Cignetti, MD PhD, Nathalie Santoro, Angela Gueli, MD, Angela Rita Elia, PhD, Giuseppina Prato, PhD, Giovanni De Rosa, MD, Mauro Papotti, Corrado Tarella, MD

Blood (2014) 124 (21): 2970.

https://doi.org/10.1182/blood.V124.21.2970.2970

Published: 2014

Journal Articles

Molecular and Functional Analysis of Peripheral Lymphocytes in Churg Strauss Syndrome Reveals Several Monoclonal Expansions of CD8+ Cells with a Th1/Proinflammatory Profile

Monica Boita, Paola Circosta, Giuseppe Guida, Angela Rita Elia, Enrico Heffler, Massimo Geuna, Corrado Tarella, MD, Giovanni Rolla, Alessandro Cignetti, MD, PhD

Blood (2012) 120 (21): 1051.

https://doi.org/10.1182/blood.V120.21.1051.1051

Published: 2012

Journal Articles

Retargeting of Citokine-Induced Killer (CIK) Cells with Molecularly Engrafted T-Cell Receptors (TCR): A Preclinical in Vitro and In Vivo Study

Angela Rita Elia, Giorgio Inghirami, Paola Circosta, Flavio Cristofani, Nathalie Santoro, Dario Sangiolo, Corrado Tarella, MD, Alessandro Cignetti

Blood (2011) 118 (21): 1917.

https://doi.org/10.1182/blood.V118.21.1917.1917

Published: 2011

Journal Articles

A CD8+ T-Cell Clone Directed Against AML Blasts that Recognizes a Tumor Specific Antigen Expressed Also by Solid Tumors

Angela Rita Elia, PhD, Paola Circosta, PhD, Russo Vincenzo, PhD, Lia Mele, PhD, Bernardino Allione, PhD, Corrado Tarella, PhD, Alessandro Cignetti

Blood (2010) 116 (21): 4289.

https://doi.org/10.1182/blood.V116.21.4289.4289

Published: 2010

Journal Articles

Leukemic Dendritic Cells Expand Central Memory T Lymphocytes From HCT Donors Able to React against the Original Leukemia in Vitro and In Vivo.

Monica Casucci, Serena Kimi Perna, Attilio Bondanza, Zulma Magnani, Massimo Bernardi, Alessandro Crotta, Cristina Tresoldi, Katharina Fleischhauer, Elena Provasi, Maurilio Ponzoni, Federico Caligaris-Cappio, Fabio Ciceri, Claudio Bordignon, Alessandro Cignetti, Chiara Bonini

Blood (2009) 114 (22): 4090.

https://doi.org/10.1182/blood.V114.22.4090.4090

Published: 2009

Journal Articles

MIC A/B Protein Expression Associates with Trastuzumab-Resistant Breast Cancer Cells Leading to Effective Immunotherapy by Cytokine Induced Killer Cells.

Dario Sangiolo, MD, PhD, Giorgio Valabrega, MD, Giuliana Cavalloni, PhD, Sonia Capellero, Giulia Mesiano, Maja Todorovic, Cristina Cammarata, Caterina Peraldo Neia, Wanda Piacibello, MD, Alessandro Cignetti, MD, PhD, Massimo Aglietta, MD

Blood (2009) 114 (22): 4092.

https://doi.org/10.1182/blood.V114.22.4092.4092

Published: 2009

Journal Articles

Lentiviral Engineered T Regulatory Cells Effectively Inhibit Lymphocytes Alloreactivity across Major HLA Barriers

Dario Sangiolo, MD, Noela Jordaney, Giulia Mesiano, Paola Circosta, Angela Elia, Stefania Stella, Maja Todorovic, Fabrizio Carnevale-Schianca, Massimo Aglietta, Alessandro Cignetti

Blood (2008) 112 (11): 3515.

https://doi.org/10.1182/blood.V112.11.3515.3515

Published: 2008

NARROW

Reaction - Real Life Use of Ravulizumab in Italian Patients with Paroxysmal Nocturnal Hemoglobinuria a Multicenter Observational Retrospective and Prospective Cohort Study, Final Results

Patient Specific Droplet Digital PCR Targeting FLT3-ITD Allows to Detect Small Clones in Acute Leukemias at Diagnosis and during Follow-up

A Chemo-Free Bridge-to-Transplant Strategy with Venetoclax and Azacitidine for NPM1 -Mutated Acute Myeloid Leukemia in Molecular Failure

CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program

Italian Observational Study on Real-Life Use of Venetoclax in Acute Myeloid Leukemia (AVALON study): Results of Interim Analysis on Relapsed/Refractory Patients

Interleukin-2 Receptor Alpha Chain, Also Called CD25, Is a Potential Target in Acute Lymphoblastic Leukemia

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Immunolipsome Loaded Venetoclax

A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-center Study of FLT3 mutated AML patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitors Administration in the Real-Life Clinical Practice

B-ALL/NHL 2002 GMALL Protocol As First-Line Treatment in Patients with Double-Hit Lymphoma: Favorable Results in18 Consecutive Patients from Two Italian Institutions

Prognostic Impact of the Baseline Immunologic Profile in Patients with Aggressive B Non-Hodgkin Lymphomas

Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia

Low Circulating B Lymphocytes in Newly Diagnosed Follicular and Diffuse Large B Cell Lymphoma: Differences Compared to Normal Subjects and Possible Prognostic Role

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

Normal Circulating B Cells Are Markedly Reduced in Follicular Lymphoma and Diffuse Large B Cell Lymphoma at Diagnosis

Molecular and Functional Analysis of Peripheral Lymphocytes in Churg Strauss Syndrome Reveals Several Monoclonal Expansions of CD8+ Cells with a Th1/Proinflammatory Profile

Retargeting of Citokine-Induced Killer (CIK) Cells with Molecularly Engrafted T-Cell Receptors (TCR): A Preclinical in Vitro and In Vivo Study

A CD8+ T-Cell Clone Directed Against AML Blasts that Recognizes a Tumor Specific Antigen Expressed Also by Solid Tumors

Leukemic Dendritic Cells Expand Central Memory T Lymphocytes From HCT Donors Able to React against the Original Leukemia in Vitro and In Vivo.

MIC A/B Protein Expression Associates with Trastuzumab-Resistant Breast Cancer Cells Leading to Effective Immunotherapy by Cytokine Induced Killer Cells.

Lentiviral Engineered T Regulatory Cells Effectively Inhibit Lymphocytes Alloreactivity across Major HLA Barriers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only